MIAMI: Metformin may exert a long-term protective effect against neurodegenerative diseases including Alzheimer’s and Parkinson’s, new research suggests.

Findings from a retrospective longitudinal study of data from Veterans’ Affairs electronic medical records were presented June 11 here at the annual American Diabetes Association (ADA) 2016 Read More »

WASHINGTON, D.C.: A drug with the potential to slow Alzheimer’s so effectively sufferers never experience memory loss has been hailed as a “breakthrough”.

Scientists hope the pioneering therapy, which is in final stage trials, will be made widely available to patients within four to five years. Read More »

BOSTON: Researchers from the University of Pittsburgh School of Medicine have gleaned new insights into the cellular biochemistry that underpins Parkinson’s disease. The team hopes that these new clues will help design effective drugs in the future.

Parkinson’s disease (PD) is a degenerative condition that Read More »

WASHINGTON, D.C.: The app is aimed at providing cookery instructions to those with significant brain damage as part of the Welsh Government and UK Innovation funded Small Business Research Initiative (SBRI).

Dr Rudi Coetzer, Consultant Neuropsychologist with the North Wales Brain Injury Service and Project Sponsor Read More »